Month: September 2022

GBT will be attending the Interactive MoneyShow Virtual Expo, on Sep 27-29, Presenting its Technologies, Innovations and Future Visions

Written by Customer Service on September 28, 2022. Posted in Public Companies.

SANTA MONICA, Calif., Sept. 28, 2022 (GLOBE NEWSWIRE) — GBT Technologies Inc. (OTC PINK: GTCH) (“GBT” or the “Company”), will be attending the Interactive MoneyShow Virtual Expo on September 27-29 (https://online.moneyshow.com/2022/september/virtual-expo/). The MoneyShow Virtual Expo is an award-winning, educational conference for investors and traders. The conference will be hosting over 50 world-class financial experts and industry-leading companies. Its main aim is to help investors harness today’s volatile markets with real-time insights, strategies and recommendations on everything from stocks, bonds, and ETFs to options, commodities, futures and forex. While recent market volatility can be extremely challenging, the expo will focus on trading opportunities understanding the catalysts driving markets and how they are...

Reunion Neuroscience Inc. Appoints Greg Mayes as President and Chief Executive Officer

Written by Customer Service on September 28, 2022. Posted in Public Companies.

Bringing a 20-Year Track Record of Success in the Biopharma Industry, Mayes Succeeds Joseph del Moral, Who Assumes the Role of Chairman TORONTO, Sept. 28, 2022 (GLOBE NEWSWIRE) — Reunion Neuroscience Inc. (TSX: REUN, NASDAQ: REUN) (“Reunion” or the “Company”), a leader in novel psychedelic drug development committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds, announced the appointment of Greg Mayes as President and Chief Executive Officer. As Reunion’s new President and CEO, Mr. Mayes’ initial focus will be on the successful completion of the Company’s Phase 1 clinical trial with its lead asset, RE-104, a novel serotonergic psychedelic, which commenced in August 2022, and the planned launch of its Phase 2 study in postpartum depression,...

Dynacor Declares October 2022 Monthly Dividend

Written by Customer Service on September 28, 2022. Posted in Public Companies.

MONTREAL, Sept. 28, 2022 (GLOBE NEWSWIRE) — Dynacor Group Inc. (TSX: DNG) (Dynacor or the Corporation) announced its monthly dividend. The declaration of a dividend payment of C$0.0083 per common share will be payable on October 19, 2022, to shareholders of record as of the close of business on October 10, 2022. This dividend represents the thirty first (31st) dividend and twenty first (21st) monthly payment made to shareholders. The Corporation’s monthly dividend qualifies as an “eligible dividend” for Canadian income tax purposes.The payment and increase of dividends are at the discretion of the Board and will depend on the Corporation’s financial results, cash requirements, prospects and other factors deemed relevant by the Board. ABOUT DYNACOR Dynacor is a dividend-paying industrial gold ore processor headquartered in Montreal,...

Nephros Partners with Donastar and Tractor Beverage Company to Supply and Service Nationwide Fast-Casual Restaurant Operation

Written by Customer Service on September 28, 2022. Posted in Public Companies.

SOUTH ORANGE, NJ, Sept. 28, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced it has shipped 3,000 commercial water filters as part of its ongoing annual contract with Donastar Enterprises LLC and Tractor Beverage Co. in service of a national chain of fast-casual restaurants. “Earlier this year we established ourselves as an approved vendor for a national and widely recognized Quick Service Restaurant (QSR) chain. The completion of this initial delivery is an important milestone in our continuing relationship, and a marker of success for the Nephros commercial water filtration business,” said Andy Astor, President and Chief Executive Officer. “The initial results...

Golden Tag to Attend 121 Mining Investment Conference in New York

Written by Customer Service on September 28, 2022. Posted in Public Companies.

TORONTO, Sept. 28, 2022 (GLOBE NEWSWIRE) — Golden Tag Resources Ltd. (“Golden Tag” or the “Company“) (TSX.V: GOG) (OTCQB: GTAGF) is pleased to announce the Company is participating in the upcoming 121 Mining Investment Conference in New York. Greg McKenzie, President & CEO of Golden Tag will be presenting about the Companies recent and future planned activities. The 121 Mining Investment Conference hosts over 60 companies joined by over 300 sophisticated investors for pre-arranged targeted 1-2-1 meetings. This year’s event is being held on October 6-7, 2022 in Midtown Manhattan. About 121 Investment 121 Mining Investment events gather senior investors from institutional funds, private equity groups, family offices and sector analysts to meet with carefully selected mining company management teams in the world’s...

Geophysical Surveys Yield Strong Conductors Associated with High-Grade Mineralization, at the Marshall Lake VMS Property, Ontario

Written by Customer Service on September 28, 2022. Posted in Public Companies.

TORONTO, Sept. 28, 2022 (GLOBE NEWSWIRE) — Copper Lake Resources Ltd. (TSX-V: CPL, Frankfurt: WOI, OTC: WTCZF) (“Copper Lake” or the “Company”) is pleased to provide the following update on the exploration program at its Marshall Lake copper-zinc-silver VMS project, situated in northern Ontario, as well as a corporate update. Large-Loop Electromagnetic Survey A large-loop EM survey (“LLEM”) was recently completed in the vicinity of the Deep IP discovery, where a new high-grade base and precious metal occurrence was discovered during diamond drilling in the winter of 2022. Highlighting the results of drill hole MAR-22-01, were the following drill intercepts:8.13% Cu1, 7.26% Zn, 240.80 g/t Ag & 0.33 g/t Au (13.59% CuEQ2) over 2.11 metres; 5.81% Cu, 7.32% Zn, 171.20 g/t Ag & 0.02 g/t Au (10.45% CuEQ) over 1.95 metres; 2.37%...

KemPharm Announces Positive Topline Data from Phase 1 Clinical Trial Evaluating Cardiovascular Safety of Serdexmethylphenidate (SDX)

Written by Customer Service on September 28, 2022. Posted in Public Companies.

SDX administered at single doses of 80 mg and 200 mg was well-tolerated CELEBRATION, Fla., Sept. 28, 2022 (GLOBE NEWSWIRE) — KemPharm, Inc. (NasdaqGS: KMPH) (KemPharm, or the Company), a specialty pharmaceutical company focused on the discovery, development and commercialization of novel treatments for rare central nervous system (CNS), neurodegenerative and lysosomal storage diseases, today announced topline data from its exploratory Phase 1 clinical trial confirming the relative cardiovascular effects and pharmacokinetics of serdexmethylphenidate (SDX) compared to immediate-release and long-acting formulations of Ritalin® (racemic methylphenidate), a commonly prescribed CNS stimulant. SDX, KemPharm’s proprietary prodrug of d-methylphenidate (d-MPH), is the sole active pharmaceutical ingredient (API) in KP1077, a potential treatment...

Aircraft Communication System Market worth $12.8 billion by 2027 – Exclusive Report by MarketsandMarkets™

Written by Customer Service on September 28, 2022. Posted in Mergers And Acquisitions.

Chicago, Sept. 28, 2022 (GLOBE NEWSWIRE) — Aircraft Communication System Market is projected to grow from USD 8.2 billion in 2022 to USD 12.8 billion by 2027, at a CAGR of 9.2% from 2022 to 2027, according to a new report by MarketsandMarkets™. The demand for Iris SATCOM and data links such as L-DACS to meet the need of various types of aircraft communications is driven by the rising demand for internet protocol (IP) based broadband. Additionally, it is also anticipated that during the forecast period, the use of commercial off the shelf technology in aircraft communication systems would boost the markets growth globally. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=108393837 Browse in-depth TOC on “Aircraft Communication System Market”257 – Tables67 – Figures285 – Pages The eVTOL/eSTOL segment...

Pancreatic Cancer Treatment Market Size [2022-2029] | Industry Share, Revenue, Key Players, CAGR, Demand and Forecast

Written by Customer Service on September 28, 2022. Posted in Mergers And Acquisitions.

Companies Profiled in the Pancreatic Cancer Treatment Market are Novartis AG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, PharmaCyte Biotech, Inc., CLOVIS ONCOLOGY, CELGENE CORPORATION, Teva Pharmaceutical Industries Ltd, Among others Pune, India, Sept. 28, 2022 (GLOBE NEWSWIRE) — The global pancreatic cancer treatment market size is expected to rise substantially owing to increasing consumption of cigarettes and rising incidents of cancer across the globe. Fortune Business Insights, published this information in its latest report, titled “Pancreatic Cancer Treatment Market Size, Share & Industry Analysis, By Type (Exocrine Pancreatic Cancer, Endocrine Pancreatic Cancer), By Treatment (Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Drug Therapy, Others), By End User (Hospitals, Specialty Clinics, Research Laboratories,...

Hemophilia Drugs Market Size to Hit USD 15,830.3 million by 2026

Written by Customer Service on September 28, 2022. Posted in Mergers And Acquisitions.

According to Fortune Business Insights™, The global Hemophilia Drugs Market size is expected to reach USD 15,830.3 million by 2026, at a CAGR of 6.0% during the forecast period, 2019-2026 Pune, India, Sept. 28, 2022 (GLOBE NEWSWIRE) — The Global Hemophilia Drugs Market covered the value of US$ 9,875.4 million in the year 2018 and is anticipated to reach US$ 15,830.3 million by 2026. Furthermore, the global market for hemodialysis is expected to report a CAGR of 6.0% during the forecast period. KEY INDUSTRY DEVELOPMENTSJuly 2021- BioMarin Pharmaceutical Inc declared the European Medicines Agency (EMA) approval for marketing authorization of its investigational gene therapy, valoctocogene roxaparvovec, for adults who are dealing with severe hemophilia A. May 2021 – CSL Behring declared the completion of commercialization and licensing...

Month: September 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals